Replies to post #36621 on Amarin Corp Plc (AMRN)

[birzinho]

JL totally agree,

We need to concentrate on CVD, what EPA does, what statins do, what the FDA has done and why they might have done it.

I'd begin with the Amarin and Vascepa situation & perspective soon after the Marine approval (with a short and understandable description of Vascepa drug clinical value & promises in comparison with alternative drugs - spelling out the names of BPs behind these other drugs).

Then list in chronological order FDA "misdeeds" (and the contemporary effects they had on the Company value).

At this point we'll try to go deeper in Vascepa promises, by the point of view of "what patients are missing" each time referring to the various acts of FDA delaying tactic.

The rest could be the many circunstances and coincidence that can lead to "suspect" criminal behaviors and interests.

>b.